Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors - A Phase I-II Sequential Chemotherapy Protocol of Bevacizumab (Avastin) Plus High-dose ICE (Ifosfamide - Carboplatin - Etoposide) Intensification
Phase of Trial: Phase I/II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Bevacizumab (Primary) ; Autologous stem cell therapy; Carboplatin; Etoposide; Filgrastim; Ifosfamide
- Indications Germ cell and embryonal neoplasms
- Focus Adverse reactions; Therapeutic Use
- Acronyms TAXIF III
- 23 Jun 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Mar 2017.
- 23 Jun 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017.
- 30 Oct 2013 New trial record